30.8 C
Vientiane
Friday, September 12, 2025
spot_img

Cision PR Newswire

Algorand Convenes Humanitarian Aid Payments Council, Welcomes New Members Across Aid, Finance, and Blockchain

New members include UNHCR, Mastercard, Paycode, Coala Pay, Meld, and Rahat SINGAPORE, Sept. 12, 2025 /PRNewswire/ -- The Algorand Foundation announced a successful meeting of its...

LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq

BEIJING, Sept. 12, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma"...

Origin Agritech Announces Appointment of Two New Independent Directors and Board Restructuring

Streamlined Board to Support the Company's Growth and Governance Objectives BEIJING, Sept. 12,...

Xinhua Silk Road: 2025 Asian Rowing U-19&U-23 Championships held in NE. China’s Shenyang

BEIJING, Sept. 12, 2025 /PRNewswire/ -- The 2025 Asian Rowing U-19&U-23 Championships concluded on...

Invitation to showcase of tidal energy kite ‘Dragon 4’ at Minesto workshop in Gothenburg, 8 October 2025

GOTHENBURG, Sweden, Sept. 12, 2025 /PRNewswire/ -- Minesto invites investors and the public with...

Gianna Lullume Baby Soother Device Officially Launches on Kickstarter

HONG KONG, Jan. 13, 2025 /PRNewswire/ -- Gianna Lullume, an innovative brand committed to improving infant sleep and promoting family well-being, is proud to...

Simcere Zaiming and AbbVie Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma

SHANGHAI and NORTH CHICAGO, Ill., Jan. 13, 2025 /PRNewswire/ -- Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096) and AbbVie Inc....

LG Innotek Reasserts Its Leadership in the Future Mobility Market at CES 2025

Exhibition booth attracts 65,000 cumulative visitors, showcasing innovative mobility components Innovative technologies presented through a 'User-Centric storytelling' approach elicit strong acclaim, inquiries from...

Dx&Vx Presents a New Paradigm for Next-Generation Infectious Disease Response with the Development of a Universal Vaccine

- Preparing for Phase 2 Global Trials of a Ferritin Platform-Based Virus-Like Particle Universal Coronavirus Vaccine - Based on the Excellent Safety and Immune Response in...

Trillium Flow Technologies Successfully Completes Refinancing

STAMFORD, Conn., Jan. 13, 2025 /PRNewswire/ -- Trillium Flow Technologies ("Trillium"), a portfolio company of First Reserve, and a global designer, manufacturer, and aftermarket...

ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow

The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro, extending ZEISS' LVC market leadership with treatment for myopia, hyperopia, and mixed...